What are examples of complete cardiac diagnoses—including etiology, anatomic findings, physiologic status, and prognosis—for a 68‑year‑old male with hypertension, type 2 diabetes, hyperlipidemia, a 30‑pack‑year smoking history presenting with progressive dyspnea on exertion, orthopnea, lower‑extremity edema, and elevated jugular venous pressure, and for a 55‑year‑old female with no significant past medical history presenting with exertional chest tightness, a systolic murmur radiating to the carotid arteries, occasional presyncope, and normal vital signs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Complete Cardiac Diagnosis Framework

A complete cardiac diagnosis systematically integrates four essential components: etiology (underlying cause), anatomic findings (structural abnormalities), physiologic status (functional impairment), and prognosis (expected clinical course and outcomes). 1

The Four Elements of Complete Cardiac Diagnosis

1. Etiology (Underlying Cause)

The etiology identifies the root cause of cardiac disease:

  • Ischemic heart disease – coronary artery disease causing myocardial damage 2, 3
  • Hypertensive heart disease – chronic elevated blood pressure leading to cardiac remodeling 2, 4
  • Diabetic cardiomyopathy – metabolic dysfunction causing myocardial changes independent of coronary disease 5, 6
  • Valvular disease – degenerative calcific changes, congenital abnormalities, or rheumatic disease 7, 8, 9
  • Cardiomyopathy – dilated, hypertrophic, or restrictive patterns 2, 4
  • Congenital defects – structural abnormalities present from birth 10

2. Anatomic Findings (Structural Abnormalities)

Anatomic assessment defines the specific structural pathology:

  • Ventricular dimensions and wall thickness – left ventricular hypertrophy, chamber dilation, or concentric remodeling 5, 6
  • Valvular pathology – stenosis severity (valve area <1.0 cm² for severe aortic stenosis), regurgitation grade, leaflet calcification 7, 8, 9
  • Coronary anatomy – number of diseased vessels, location and severity of stenoses, presence of occlusions 3
  • Atrial enlargement – left atrial volume index as marker of chronic diastolic dysfunction 11
  • Conduction system abnormalities – complete heart block, bundle branch blocks 11

3. Physiologic Status (Functional Impairment)

Physiologic assessment quantifies the functional consequences:

  • Left ventricular ejection fraction – preserved (≥50%), mildly reduced (40-49%), moderately reduced (30-39%), or severely reduced (<30%) 11, 4, 12
  • Diastolic function – E/A ratio, E/e' ratio, left atrial pressure estimation 5, 6
  • Hemodynamic parameters – transvalvular gradients (mean gradient ≥40 mmHg for severe aortic stenosis), pulmonary artery pressures, cardiac output 10, 9
  • NYHA functional class – Class I (asymptomatic), II (mild limitation), III (marked limitation), or IV (symptoms at rest) 2, 4, 12
  • Presence of obstruction – left ventricular outflow tract gradient in hypertrophic cardiomyopathy 2
  • Congestion status – elevated jugular venous pressure, pulmonary congestion on imaging 13, 4

4. Cardiac Status and Prognosis

Prognosis integrates clinical, functional, and anatomical data to predict outcomes:

  • Risk stratification factors – age >65 years, reduced LVEF, elevated serum creatinine >121 μmol/L, serum sodium ≤137 mmol/L, elevated plasma urea >7.6 mmol/L 12
  • Exercise capacity – 6-minute walk distance, maximal exercise time, heart rate response to exercise 12
  • Biomarker elevation – NT-proBNP levels reflecting hemodynamic stress 13
  • Comorbidity burden – diabetes, chronic kidney disease, peripheral arterial disease 3, 14
  • Expected mortality – annual mortality ranges from 0.6% in stable coronary disease to 32% at 2 years in heart failure 3, 12

Clinical Examples

Example 1: 68-Year-Old Male with Heart Failure

Complete Diagnosis:

  • Etiology: Ischemic cardiomyopathy secondary to coronary artery disease with contributing hypertensive heart disease and diabetic cardiomyopathy 15, 5, 6
  • Anatomy: Triple-vessel coronary disease; left ventricular dilation with regional wall motion abnormalities (anterior, lateral, inferior walls); left ventricular hypertrophy; left atrial enlargement 3
  • Physiology: Heart failure with reduced ejection fraction (LVEF 30-35%); NYHA Class III symptoms; elevated left ventricular filling pressures (E/e' >15); volume overload with elevated jugular venous pressure and lower extremity edema 13, 4, 12
  • Prognosis: High-risk profile with 2-year mortality approximately 30-40% based on reduced LVEF, NYHA Class III, multiple comorbidities (hypertension, diabetes, hyperlipidemia), and 30-pack-year smoking history 12, 14

Example 2: 55-Year-Old Female with Valvular Disease

Complete Diagnosis:

  • Etiology: Degenerative calcific aortic stenosis (age-appropriate) 9
  • Anatomy: Severe aortic stenosis with valve area <0.8 cm²; heavily calcified trileaflet aortic valve; concentric left ventricular hypertrophy; normal coronary arteries 7, 8, 9
  • Physiology: Severe obstruction with mean transvalvular gradient ≥40 mmHg; preserved left ventricular ejection fraction (>50%); symptomatic with exertional chest tightness and presyncope; systolic murmur radiating to carotids 7, 8, 9
  • Prognosis: Critical symptomatic aortic stenosis carries high mortality without intervention (50% mortality at 2 years once symptoms develop); excellent prognosis with aortic valve replacement (surgical or transcatheter) 9

Key Diagnostic Pitfalls

Avoid incomplete diagnoses that omit critical elements:

  • Stating only "heart failure" without specifying ejection fraction, etiology, or NYHA class provides insufficient information for treatment decisions 4, 1
  • Describing "coronary artery disease" without quantifying vessel involvement, stenosis severity, or ischemic burden fails to guide revascularization strategy 3
  • Reporting "aortic stenosis" without valve area, gradient, symptoms, and ventricular function prevents appropriate timing of intervention 9

Recognize that physical examination findings require correlation with objective testing:

  • Systolic murmurs require echocardiographic confirmation of severity and hemodynamic significance 7, 8
  • Clinical signs of congestion (edema, elevated JVP) may resolve with diuretics but underlying structural disease persists 4
  • Absence of symptoms does not exclude severe disease, particularly in elderly patients who limit activity 9

Integrate multiple comorbidities into risk assessment:

  • Diabetes, hypertension, and hyperlipidemia synergistically increase cardiovascular risk beyond individual contributions 14, 16
  • Chronic kidney dysfunction (creatinine >121 μmol/L) independently predicts mortality in heart failure 13, 12
  • Visceral adiposity correlates with diastolic dysfunction and left ventricular hypertrophy independent of glycemic control in diabetes 6

References

13
Guideline

kidney dysfunction in heart failure: core curriculum 2025.

American Journal of Kidney Diseases, 2025

Related Questions

Is a 20‑lb weight gain by 26 weeks gestation appropriate for a woman with a normal pre‑pregnancy BMI, and what dietary and activity recommendations should I follow?
For a 21‑year‑old male with mild hypertension (office BP 153/82 mmHg, home average 122/65 mmHg), a small atrial septal defect, allergic rhinitis, mild hyperlipidaemia, and a BMI of 23, what ASA (American Society of Anesthesiologists) physical status classification is appropriate?
In a 25-year-old patient with a total cholesterol of 291 mg/dL and triglycerides of 412 mg/dL, what treatment should be initiated?
What is the appropriate management for a 27-year-old female with total cholesterol of 219 mg/dL, LDL cholesterol of 139 mg/dL, and apolipoprotein B of 104 mg/dL?
What is the recommended management for an 11-year-old with elevated cholesterol?
What is the appropriate analgesic for abdominal pain in a patient with dengue?
Does a diagnosis of osteoporosis require a bone density scan (dual‑energy X‑ray absorptiometry, DXA)?
What are the best next steps for an ANA‑positive patient with a urine albumin‑to‑creatinine ratio of 714 mg/g and a low anti‑SSB (Ro) titer of 1.3?
In a 71‑year‑old woman with a very high atypical P‑ANCA (perinuclear anti‑neutrophil cytoplasmic antibodies) titer, markedly elevated free κ and λ light chains, increased γ‑globulin and total globulin, what is the likely diagnosis and what diagnostic work‑up and initial treatment should be pursued?
How should neonatal tetanus be managed in a newborn?
How should I manage a patient with vaginal discharge and mild odor whose urine culture shows trace leukocyte esterase, squamous epithelial cells, and bacteria?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.